what is glp-1 used for Glucagon-like peptide-1 GLP-1 receptor agonists | How

Although approximately 40% of plan members were estimated to have obesity, the $83 million projected annual cost of the coverage was based on the assumption that only 10% of eligible members would utilize these therapies

Morton says

The MERIT randomized trial reported 13.6% mean total body weight loss at 12 months, with peer-reviewed series typically showing 15-17.5% loss at 12-24 months

I mean, I felt like I was eating nothing but dry Cheerios and plain bread and carrots, Kochman said

It also sounds too good to be true, because in most cases, it is

Wegovy (semaglutide 2.4mg weekly injection) carries the chronic weight management indication